Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease

被引:0
作者
Sumit R. Majumdar
Jerry H. Gurwitz
Stephen B. Soumerai
机构
[1] Harvard Medical School and Harvard Pilgrim Health Care,Department of Ambulatory Care and Prevention
[2] University of Massachusetts Medical School,The Meyers Primary Care Institute
[3] and the Fallon Healthcare System,undefined
来源
Journal of General Internal Medicine | 1999年 / 14卷
关键词
hyperlipidemia; treatment; guidelines; secondary prevention; coronary artery disease;
D O I
暂无
中图分类号
学科分类号
摘要
OBJECTIVES: To determine adherence to national guidelines for the secondary prevention of coronary artery disease (CAD) using lipid-lowering drugs (LLDs), by studying the rate of use of LLDs, predictors of use, and the rate of achieving lipid goals, among eligible patients recently hospitalized with acute myocardial infarction.
引用
收藏
页码:711 / 717
页数:6
相关论文
共 137 条
  • [1] Soumerai SB(1988)Factors influencing prescribing Aust J Hosp Pharm 18 9-16
  • [2] Lamas GA(1992)Do the results of randomized trials of cardiovascular drugs influence medical practice? N Engl J Med 327 241-7
  • [3] Pfeffer MA(1990)The cholesterol facts—a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease Circulation 81 1721-33
  • [4] Hamm P(1996)Cholesterol reduction: weighing the benefits and risks Ann Intern Med 124 914-8
  • [5] La Rosa JC(1996)Lipid lowering therapy for patients with or at risk of coronary artery disease Curr Opin Cardiol 11 418-27
  • [6] Hunninghake D(1997)Cholesterol management in theory and practice Circulation 96 4424-30
  • [7] Bush D(1992)HMG CoA reductase inhibitors: a look back and a look ahead Can J Cardiol 8 843-88
  • [8] Gaziano JM(1993)Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) JAMA 269 3015-23
  • [9] Hebert PR(1994)Randomized trial of cholesterol lowering in 4444 with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1383-9
  • [10] Hennekens CH(1994)Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987–92 Chest 105 1687-92